The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
Most employers are expecting to hire this year, according to BioSpace data and Recruitment Manager Greg Clouse, who noted ...
This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, BioSpace and Yahoo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback